Apyx Medical
APYX
54 hedge funds and large institutions have $94M invested in Apyx Medical in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 15 closing their positions.
202% more call options, than puts
Call options by funds: $142K | Put options by funds: $47K
0% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 19
0.52% less ownership
Funds ownership: 61.05% → 60.54% (-0.52%)
14% less funds holding
Funds holding: 63 → 54 (-9)
24% less capital invested
Capital invested by funds: $123M → $94M (-$29.3M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$2.97M |
| 2 |
IP
Invenire Partners
Ridgefield,
Connecticut
|
+$2.63M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$1.32M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$801K |
| 5 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
+$621K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$1.83M |
| 2 |
Millennium Management
New York
|
-$1.21M |
| 3 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$1.08M |
| 4 |
E
Ergoteles
New York
|
-$852K |
| 5 |
Renaissance Technologies
New York
|
-$816K |
APYX Hedge Fund Activity: Q3 2022 in Review
54 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2022, worth a combined $94M — down 24% from $123M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of APYX and 6 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 19 added.
The largest buyer was Royce & Associates, adding an estimated $2.97M. The largest seller was Next Century Growth Investors, cutting an estimated $1.83M.
- 54 institutional investors held Apyx Medical (APYX) as of Q3 2022, down from 63 in Q2 2022.
- Funds reported $94M of Apyx Medical stock for Q3 2022, down 24% quarter-over-quarter.
- 6 funds opened new Apyx Medical positions in Q3 2022 and 15 closed out, a net change of -9 holders.
- The largest Apyx Medical buyer in Q3 2022 was Royce & Associates, an estimated $2.97M added.
- The largest Apyx Medical seller in Q3 2022 was Next Century Growth Investors, an estimated $1.83M sold.
Based on aggregated 13F filings for Q3 2022.